Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2013
10/17/2013WO2013154709A1 Maternal biomarkers for gestational diabetes
10/17/2013WO2013154654A1 Reporting and self-decontaminating articles for individual hazard detection and protection
10/17/2013WO2013154460A1 Nano-antibody specifically binding cea protein, and method for using said nano-antibody for detecting said protein
10/17/2013WO2013154429A1 Multiplex reporter assays for monitoring multiple variables
10/17/2013WO2013154422A1 Biomarkers for triple negative breast cancer
10/17/2013WO2013154308A1 Device and method for measuring hemoglobin
10/17/2013WO2013154213A1 Diagnostic cartridge
10/17/2013WO2013154208A1 Method for identifying and quantifying types of animal hair
10/17/2013WO2013154206A1 Anti-fgfr2 antibody
10/17/2013WO2013154128A1 Novel arteriosclerosis treatment drug composition and method for screening arteriosclerosis treatment drugs
10/17/2013WO2013154091A1 Method for evaluating slip sheet for glass plate
10/17/2013WO2013153735A1 Blood coagulation system analyzer, blood coagulation system analysis method and program
10/17/2013WO2013153524A1 Methods for determining a breast cancer-associated disease state and arrays for use in the methods
10/17/2013WO2013153507A2 Method of assessing infection status
10/17/2013WO2013153397A1 Improved blood glucose testing with hematocrit correction
10/17/2013WO2013153392A1 Biosensors
10/17/2013WO2013153386A1 Parkinson's disease biomarker
10/17/2013WO2013153355A1 An assay label
10/17/2013WO2013153311A1 Method for determining geomechanical parameters of a rock sample
10/17/2013WO2013153291A1 Method and kit for detecting the lh preovulatory surge
10/17/2013WO2013153177A1 Prognosis of adverse events in patients with suspected chronic heart failure
10/17/2013WO2013152989A2 Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
10/17/2013WO2013152977A1 Method for detecting and/or monitoring the solid content in the conveying of untreated water out of wells
10/17/2013WO2013152919A1 Detection of platelet-derived shed cd31
10/17/2013WO2013152687A1 Preparation method of near-infrared fluorescent dye and application thereof
10/17/2013WO2013152385A1 Method and apparatus for assessing shear strength development in cementitious materials
10/17/2013WO2013126774A3 Microfluidic devices for capture of target species
10/17/2013WO2013109549A3 Methods, devices, and systems for measuring physical properties of fluid
10/17/2013WO2013109302A3 Chromatography matrices including novel staphylococcus aureus protein a based ligands
10/17/2013WO2013092611A3 Method for the detection of free binding partner of a multispecific binder
10/17/2013WO2013088098A3 Efficient ultra-long dna analysis in compact nanofluidic channels
10/17/2013WO2013081571A3 Isolated lyssavirus nucleic acid and protein sequences
10/17/2013WO2013080055A3 Molecular display method
10/17/2013WO2013078477A3 Solubilization of curcuminoid compounds and products thereof
10/17/2013WO2012094658A3 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
10/17/2013WO2012051205A3 Devices, systems and methods for the collection of body fluids
10/17/2013US20130276158 Methods and compositions for rna interference
10/17/2013US20130275053 Computer implemented method for analyzing a gas sample using an inline gas analyzer
10/17/2013US20130274617 Biological information monitoring apparatus
10/17/2013US20130274574 Electrochemical Analyte Sensor
10/17/2013US20130274453 Detection of Degradation Products of Feline NT-proBNP
10/17/2013US20130274438 Analogs of ShK Toxin and Their Uses in Selective Inhibition of Kv1.3 Potassium Channels
10/17/2013US20130274286 NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NMPRTase) INHIBITOR FOR GLIOMA THERAPY
10/17/2013US20130274172 Single domain tdf-related compounds and analogs thereof
10/17/2013US20130274145 Anti-TNF Alpha Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses
10/17/2013US20130274143 Use of detector response curves to optimize settings for mass spectrometry
10/17/2013US20130274142 Cell Co-Culture Systems and Uses Thereof
10/17/2013US20130274137 Method and system for detecting a target within a population of molecules
10/17/2013US20130274136 Prostate cancer point of care diagnostics
10/17/2013US20130274134 Analytical Methods and Arrays for Use in the Same
10/17/2013US20130274131 Advanced Reverse-phase Magnetic Immunoassay
10/17/2013US20130274130 Sensitive high throughput method for dna damage and repair
10/17/2013US20130274128 Gene expression in n-cadherin overexpressing prostate cancers and their controls
10/17/2013US20130274125 Multiplex immunoassay for rheumatoid arthritis and other autoimmune diseases
10/17/2013US20130274124 Adhesion signatures
10/17/2013US20130274123 Maternal biomarkers for gestational diabetes
10/17/2013US20130274119 Methods and apparatuses for detection of positional freedom of particles in biological and chemical analyses and applications in immunodiagnostics
10/17/2013US20130273645 Detection instrument, and detection system
10/17/2013US20130273644 Nucleic acid amplification reaction station for disposable test devices
10/17/2013US20130273643 Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
10/17/2013US20130273642 Device and method for detection of analytes
10/17/2013US20130273641 System and method of verification of a prepared sample for a flow cytometer
10/17/2013US20130273599 Photo-coupled data acquisition system and method
10/17/2013US20130273595 Method for determining age of ginseng roots using chromatogramphy-mass spectroscopy
10/17/2013US20130273589 Microfluidic device for cell culture
10/17/2013US20130273588 Method for screening drugs for suppressing inflammasome activity
10/17/2013US20130273580 Elisa assay kit, elisa for determining desmosine levels from urine samples and diagnostic urine assays for aneurysms
10/17/2013US20130273579 Method for analyzing proteins contributing to autoimmune diseases, and method for testing for said diseases
10/17/2013US20130273578 Method of detecting calcifying nanoparticles and susceptibility to calcifying nanoparticle formation
10/17/2013US20130273577 Detection of dysplastic or neoplastic cells using anti-mcm3 antibodies
10/17/2013US20130273576 Reagents for reducing leukocyte interference in immunoassays
10/17/2013US20130273575 Method for Assaying Fibroblast Growth Factor-23 and Assay Reagent
10/17/2013US20130273574 Oligomeric a-beta in the diagnosis, prognosis, and monitoring of alzheimer's disease
10/17/2013US20130273573 Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's disease
10/17/2013US20130273572 Methods for Diagnosing Lyme Disease
10/17/2013US20130273571 Method of functionalizing human red blood cells with antibody
10/17/2013US20130273570 Method for identification and culture of multipotent mesenchymal stem cells with high proliferation potential
10/17/2013US20130273568 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
10/17/2013US20130273567 Screening Method for Candidate Agonist Compounds for Adiponectin Receptor I
10/17/2013US20130273566 Serological Markers of Inflammatory Bowel Disease Phenotype and Disease Progression
10/17/2013US20130273565 Polymeric carriers for immunohistochemistry and in situ hybridization
10/17/2013US20130273564 Dispersion injection methods for biosensing
10/17/2013US20130273563 Device for performing an enzyme-based diagnostic test and methods for use thereof
10/17/2013US20130273562 1L1RL-1 as a Cardiovascular Disease Marker and Therapeutic Target
10/17/2013US20130273561 Lipid encapsulation of surface enhanced raman scattering (sers) nanoparticles
10/17/2013US20130273558 Treatment of Conditions Involving Demyelination
10/17/2013US20130273557 Compounds and methods of modulating mitochondrial bioenergetic efficiency through an interaction with atp synthase (complex v) and its subunits
10/17/2013US20130273545 Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease
10/17/2013US20130273540 Method for chromogenic detection of two or more target molecules in a single sample
10/17/2013US20130273534 Socs-3 promoter methylation in cancer
10/17/2013US20130273533 Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
10/17/2013US20130273532 Upregulation of rack-1 in melanoma and its use as a marker
10/17/2013US20130273528 Device for performing a diagnostic test and methods for use thereof
10/17/2013US20130273527 Method for inducing cell senescence by recombinant interferon with altered spatial configuration
10/17/2013US20130273525 Multiplex method for detecting an infection
10/17/2013US20130273111 Diagnostic assays and methods of use for detection of filarial infection
10/17/2013US20130273096 Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
10/17/2013US20130273085 Novel P2X7 Epitopes
10/17/2013US20130273083 System for Immunotherapy Targeting Tumor Propagation and Progression
10/17/2013US20130273076 Method for determining activators of excitatory synapse formation
1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 3937